logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
15/09/2026
Moody's changes Bangladesh's rating outlook to stable, affirms B2 rating.
Latest
3 m ago
Yuwell Medical: Cumulative repurchase of 10.3781 million shares, accounting for 1.0352%
3 m ago
US Treasury Secretary Bessent will attend a hearing of the U.S. House Financial Services Committee tonight at 22:00, with the theme "Annual Testimony by the Treasury Secretary on the State of the International Financial System." Given that the current 10-year U.S. Treasury yield has risen above 5%, the market will focus on whether Bessent sends new signals regarding fiscal policy, Treasury issuance and buyback plans, debt management, and the outlook for the dollar and interest rates. If his remarks lean toward controlling the deficit and stabilizing the bond market, this could ease upward pressure on long-end U.S. Treasury yields; if he signals more fiscal expansion or tolerance for higher interest rates, then caution is warranted over further increases in U.S. Treasury yields, and attention should be paid to the linked reactions in the dollar, gold, U.S. equities, and risk assets.
3 m ago
Mankun Technology: Abnormal Stock Trading Fluctuations, P/E Ratio Deviates from Industry Average
3 m ago
Hengxuan Technology: Plans to repurchase company shares for RMB 50 million100 million.
5 m ago
Kangchen Pharmaceutical: Hemocoagulase Agkistrodon for Injection Receives New Veterinary Drug Registration Certificate, with a 3-year Monitoring Period
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.